The challenge with dosing for psychedelics is that there isn’t any consistency between products, but methods can include volumetric measuring of a fully dissolved solution for accurate dosing. This is an important practice as many people mistakenly take doses that are too large, instead of “microdosing” as intended.
Microdosing psychedelics such as psilocybin could have therapeutic benefits for disorders such as ADHD and anxiety, but more double-blind research is needed to differentiate the effects from a placebo. However, there may be a potential overlap between therapeutic use and positive psychology in terms of improving mood and focus.